ZD-9255

N/A

Report date: 2025/02/07 11:37:38

Base Information

Drug NameZD-9255
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine receptor antagonists
TargetsAdenosine receptor
Therapy Area/IndicationsPeripheral Vascular DiseasesIntermittent ClaudicationMyocardial Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesIntermittent ClaudicationMyocardial Ischemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A